Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC NITD-688 | 2407227-31-8 | 98.0% | 500.68 | 25 MG
SDP

Catalog No. 5000348613
Encompass_Preferred

NITD-688 is an orally active pan-serotype inhibitor of the dengue virus NS4B protein. It is utilized in dengue virus (DENV) research and demonstrates antiviral activity against all four serotypes of DENV.

  • Orally active pan-serotype inhibitor of the dengue virus NS4B protein
  • Utilized in dengue virus (DENV) research
  • Exhibits antiviral activity against all four serotypes of DENV
  • Shows antiviral activity against DENV-2 infected PBMCs with an EC50 value of 0.94 nM
  • Directly binds to wild-type but not mutant NS4B protein
  • Demonstrates antiviral efficacy in infected AG129 mice
  • Well tolerated in rats and dogs

Catalog No. 50-003-48613 Supplier Medchemexpress LLC Supplier No. 25MGHY138543
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

NITD-688 is an orally active pan-serotype inhibitor of the dengue virus NS4B protein. It is utilized in dengue virus (DENV) research and demonstrates antiviral activity against all four serotypes of DENV.

  • Orally active pan-serotype inhibitor of the dengue virus NS4B protein
  • Utilized in dengue virus (DENV) research
  • Exhibits antiviral activity against all four serotypes of DENV
  • Shows antiviral activity against DENV-2 infected PBMCs with an EC50 value of 0.94 nM
  • Directly binds to wild-type but not mutant NS4B protein
  • Demonstrates antiviral efficacy in infected AG129 mice
  • Well tolerated in rats and dogs

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.